Magnetic Resonance Imaging
Volume 28, Issue 9 , Pages 1327-1334 , November 2010

MR findings of focal eosinophilic liver disease using gadoxetic acid

Received 31 March 2010 ,Accepted 10 June 2010.

References 

  1. Won JH, Kim MJ, Kim BM, Ji H, Chung JJ, Yoo HS, et al. Focal eosinophilic infiltration of the liver: a mimicker of hepatic metastasis. Abdom Imaging. 1999;24:369–372
  2. Kwak HS, Han YM, Lee JM. Focal eosinophilic infiltration of the liver mimicking hepatocellular carcinoma: case reports. Clin Imaging. 2004;28:36–39
  3. Kim YK, Kim CS, Moon WS, Cho BH, Lee SY, Lee JM. MRI findings of focal eosinophilic liver diseases. AJR Am J Roentgenol. 2005;184:1541–1548
  4. Sun JS, Kim JK, Won JH, Lee KM, Cheong JY, Kim YB. MR findings in eosinophilic infiltration of the liver. J Comput Assist Tomogr. 2005;29:191–194
  5. Yu JS, Yoon SW, Park MS, Lee JH, Kim KW. Eosinophilic hepatic necrosis: magnetic resonance imaging and computed tomography comparison. J Comput Assist Tomogr. 2005;29:765–771
  6. Byun JH, Yang DH, Yoon SE, Won HJ, Shin YM, Jeong YY, et al. Contrast-enhancing hepatic eosinophilic abscess during the hepatic arterial phase: a mimic of hepatocellular carcinoma. AJR Am J Roentgenol. 2006;186:168–173
  7. Kim WH, Kim SH, Kim YH, Youn SH, Kang WJ, Kim MA, et al. Fluorine-18-FDG PET findings of focal eosinophilic liver disease: correlation with CT and/or MRI, laboratory, and pathologic findings. Abdom Imaging. 2010;35:437–446
  8. Park MS, Kim MJ, Lim JS, Kim SH, Kim HS, Chung YE, et al. Metastasis versus focal eosinophilic infiltration of the liver in patients with extrahepatic abdominal cancer: an evaluation with gadobenate dimeglumine-enhanced magnetic resonance imaging. J Comput Assist Tomogr. 2009;33:119–124
  9. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology. 1992;183:59–64
  10. Hamm B, Staks T, Muhler A, Bollow M, Taupitz M, Frenzel T, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology. 1995;195:785–792
  11. Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT — initial observations. Radiology. 2005;234:468–478
  12. Vogl TJ, Kummel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology. 1996;200:59–67
  13. Giovagnoni A, Paci E. Liver. III: gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg). Magn Reson Imaging Clin N Am. 1996;4:61–72
  14. Tamada T, Ito K, Sone T, Yamamoto A, Yoshida K, Kakuba K, et al. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging. 2009;29:636–640
  15. Reimer P, Rummeny EJ, Daldrup HE, Hesse T, Balzer T, Tombach B, et al. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol. 1997;7:275–280
  16. Lee WJ, Lim HK, Lim JH, Kim SH, Choi SH, Lee SJ. Foci of eosinophil-related necrosis in the liver: imaging findings and correlation with eosinophilia. AJR Am J Roentgenol. 1999;172:1255–1261
  17. Kim GB, Kwon JH, Kang DS. Hypereosinophilic syndrome: imaging findings in patients with hepatic involvement. AJR Am J Roentgenol. 1993;161:577–580
  18. Yoo SY, Han JK, Kim YH, Kim TK, Choi BI, Han MC. Focal eosinophilic infiltration in the liver: radiologic findings and clinical course. Abdom Imaging. 2003;28:326–332
  19. Jang HJ, Lee WJ, Lee SJ, Kim SH, Lim HK, Lim JH. Focal eosinophilic necrosis of the liver in patients with underlying gastric or colorectal cancer: CT differentiation from metastasis. Korean J Radiol. 2002;3:240–244
  20. Kirchin MA, Pirovano GP, Spinazzi A. Gadobenate dimeglumine (Gd-BOPTA). An overview. Invest Radiol. 1998;33:798–809
  21. Spinazzi A, Lorusso V, Pirovano G, Kirchin M. Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Acad Radiol. 1999;6:282–291
  22. Runge VMA. comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA. J Comput Assist Tomogr. 1998;22:643–650

PII: S0730-725X(10)00170-0

doi: 10.1016/j.mri.2010.06.013

Magnetic Resonance Imaging
Volume 28, Issue 9 , Pages 1327-1334 , November 2010

Article Tools

* Image Usage & Resolution